Janet W. Appelbaum

Statistics

Publications

Citations

317

H-Index

Active since

1992

Affiliations

Virginia Mason Medical Center(Current)

Janet W. Appelbaum is an author at Virginia Mason Medical Center specializing in antibody-based radionuclide therapy, pharmacokinetics of monoclonal antibodies, and medicine.

Publications per year

1992–2000

Publications

Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results

Paul L. Weiden, Hazel B. Breitz, Oliver W. Press et al. · Cancer Biotherapy and Radiopharmaceuticals · 2000 · 137 citations

Medicine, Oncology, Pharmacokinetics +17

Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.

Hazel B. Breitz, Paul L. Weiden, Jean‐Luc Vanderheyden et al. · PubMed · 1992 · 119 citations

Medicine, Nuclear Medicine, Oncology +17

Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10.

Paul L. Weiden, Hazel B. Breitz, C A Seiler et al. · PubMed · 1993 · 31 citations

Medicine, Oncology, Pharmacology +17

Human anti‐mouse antibody suppression with cyclosporin A

Paul L. Weiden, Sandra B. Wolf, Hazel B. Breitz et al. · Cancer · 1994 · 30 citations

Life Sciences, Immunology, Pharmacology +12

1–4 of 4